chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No symptoms or adverse events. Mother verbally stated that child had asthma after vaccine administered. Child diagnosed in June 2012 with asthma. Flumist given 10/22/12. April 17, 2013 mother notified vaccine administrator of diagnosis, denies any symptoms or adverse events.
headache,  Injection location in right arm experienced excess tenderness, swelling  and  warm to the  touch.,  excessive fatigue, light buzzing sensation, excessive chills  muscle aches all over an d , lower back tightness
Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe
Left arm fro top of left shoulder to left elbow on lateral left axilla inflamed, warm to touch. Non-tender, no loss of function or ROM. Resolved after 2 or 3 days per patient's mother. No treatment except for Dr's evaluation & patient education on immunization reactions.
Presented with SOB and covid symptoms.  Dx with Covid PNA.  History of ESRD on peritoneal dialysis.  Treated with abx, O2, and steroids
Just after administration of influenza vaccine IM, client experienced episode of light headedness, and tightening throat. Color was pale. She was able to breathe fine and swallow without problem.  O2 sats 96% HR 103.
Extremely tired,  nauseous,  body pain,  headache,  low grade temperature.  Started the evening of the vaccine 1/5/21 and symptoms has gotten worse.
Chills, fever, muscle ache, diarrhea,   SHORTNESS OF BREATH & COUGH
Soreness near injection site, headache, body aches, fatigue - all symptoms persisted for approximately 36 hours beginning  12 hours after vaccination
ACUTE KIDNEY INJURY; ACUTE HYPOXIC RESPIRATORY FAILURE; This spontaneous report was received from literature: Characteristics and outcomes of adverse events after COVID-19 vaccination. 2021 Oct 13; 2/5. This report concerned a 92 year old male. The objective of this study was to describe fatal and non-fatal possible Adverse Events after COVID-19 vaccine administration. The patient's height, and weight were not reported. The patient's concurrent conditions included: hypertension, congestive heart failure, chronic kidney disease, and renal cancer. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced acute kidney injury and acute hypoxic respiratory failure. On an unspecified date, the patient died of acute kidney injury and acute hypoxic respiratory failure. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The authors concluded that although reported adverse events (AEs) were not necessarily caused by the vaccination, this study provided further information about possible AEs after COVID-19 immunization, especially those requiring hospital admission. This study also supported prior data that serious AEs post vaccination were much lower than primary COVID-19 infections. Also, need for further studies to investigate causalities between vaccines and reported AEs across all age groups was highlighted. This report was serious (Death).; Sender's Comments: V0: 20211045466-covid-19 vaccine ad26.cov2.s-acute kidney injury. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY 20211045466-covid-19 vaccine ad26.cov2.s-acute hypoxic respiratory failure. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: ACUTE HYPOXIC RESPIRATORY FAILURE; ACUTE KIDNEY INJURY
lymphodenopathy under my right arm / right axillary lymph node is still enlarge; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP), Program ID: (005570). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown), in right arm for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: COVID-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), administration date: Mar2021, for COVID-19 Immunization; COVID-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), administration date: Apr2021, for COVID-19 Immunization. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "not recovered", described as "lymphodenopathy under my right arm / right axillary lymph node is still enlarge". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient had both COVID-19 vaccine in Mar/Apr2021 in addition to the booster in late Dec2021 and since then, patient had been struggling with lymphadenopathy under the right arm, same arm patient received the vaccine. Patient did a memogram in Jun2022, it was okay. It had been 8 months since the booster and the right axillary lymph node was still enlarged. Patient did some research but not much studies or reports had been covered except there were some reports from Japan with similar symptoms and condition.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
resident was hospice she was afebrile day of vaccine on 4/20. on am of 4/21/21 0600 nurse stated no c/o of pain or discomfort.  Resp were even and unlabored.  That morning at 1145 charge nurse stated she was extremely hard to rouse.  Vs were ok.  SHe had some weakness in right side.  they  notified hospice.  She had labs done.  She was diagnosed with PNA and started on Abt.  That night she was unresponsive to verbal commands and couldn't get po med.  she received gentamicin im.  on 4/22/21 charted she was vommiting small amount.  She expired late that night.  MD doesn't believe the vaccine  caused the death, but thinks it has the potential.
About 20 hours after injection, I had mild flu-like symptoms, including headache and muscle ache, lasting about 12 hours. But about 5 days after my injection (5 days + 5 hours, actually), I experienced a bewildering all-over rash that freaked me out. It started as itching around my elbows and ankles -- it felt like mosquito bites and sunburn together -- and spread to wrist and knee areas. The rash climbed by legs and arms. I applied coat after coat of Benadryl, which seemed to help. The rash would disappear and move somewhere else. I had it on my left foot, but then that resolved, only to find it on my right foot. After about 3 hours, it had spread to my stomach, the bridge of my nose, and my cheeks. It started to calm down around midnight. I woke up at 6:00 am (12 hours after onset) with extremely itchy hands. At 8:00 am (14 hours after onset), it had mostly disappeared except for patches on my back, and my wrists still itch. I'm hoping it goes away later today! It was crazy!
feeling bad; Mild fever; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received on unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced feeling bad (Verbatim: feeling bad) and fever (Verbatim: Mild fever). The outcome of the feeling bad and fever were resolved (duration 1 day).   It was unknown if the reporter considered the feeling bad and fever to be related to Shingles vaccine.     It was unknown if the company considered the feeling bad and fever to be related to Shingles vaccine.   Additional Information: GSK receipt date:02-AUG-2023 This case was reported by a patient via interactive digital media. The reporter reported that he/she had finished 2 shot of vaccine.  The second shot he/she was feeling bad for the following day.  The patient had mild fever and was fine the next morning. The follow-up could not be possible as no contact details were available.
it looks and sounds like she has Bell palsy; mental fog; Nauseated; left side of face numb; left tongue felt numb and fat as though I got injected at the dentist; Then medicine taste in my mouth and some slurring; Then medicine taste in my mouth and some slurring; This is a spontaneous report from a contactable other hcp (patient). A 48-years-old female patient received first dose of BNT162B2 (Lot number and expiry date not available), via an unspecified route of administration on 21Jan2021 10:45 at single dose in the left arm for COVID-19 immunization. Medical history included Hypo thyroid (medication not needed at this time). The patient had no known allergies. Concomitant medication included cefixime (FLEXERIL) and ibuprofen (IBU). On 21Jan2021 11:00, after 15 minutes of getting the vaccine, the patient felt nauseated. Then it continued to get worse from there left side of face numb, mental fog, left tongue felt numb and fat as though she got injected at the dentist. Then medicine taste in her mouth and some slurring. Stated that her boss which is doctor side it looks and sounds like she has Bell palsy. She was prescribed Methylprednisolone and she feel somewhat better. Still waiting to feel completely myself. It's been now about 8 hours since her vaccination. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of all the events which included methylprednisolone. The outcome of the events was recovering.  Information about lot/batch number has been requested.; Sender's Comments: Based on the available information, contributory role of BNT162B2  to the onset of reported events Bell palsy and mental fog occurred 15 minutes after getting the vaccine cannot be completely excluded. The case will be reevaluated should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Reactivation of herpes breakouts, it's been years since last breakout and now it's chronic.
5 month old infant developed hives on forehead minutes after being vaccinated. Pt. was crying & irritable. VSS. Pt given BENADRYL 12.5mg/tsp 1/2tsp PO x 1. Pt sent home. Pt had same vaccines in Nov with no reported adverse rxn. Not sure if rxn was sec. to vaccine versus stress.
Pt developed a "red spot" on her L sclera about 1-1 1/2 hr after Fluzone quadrivalent vaccine. MD office notified - determined pt did not have to be seen - Ocular hyperemia is listed as Adverse side effect. Per MD red spot - possible broken vessel.
arm that swelled after a wasp stung; arm swelled all the way up to the elbow/it just kept swelling; This spontaneous case was reported by a consumer and describes the occurrence of ARTHROPOD STING (arm that swelled after a wasp stung) and PERIPHERAL SWELLING (arm swelled all the way up to the elbow/it just kept swelling) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 03B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In June 2021, the patient experienced ARTHROPOD STING (arm that swelled after a wasp stung) and PERIPHERAL SWELLING (arm swelled all the way up to the elbow/it just kept swelling). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Wasp sting, at a dose of 1 dosage form every four hours. At the time of the report, ARTHROPOD STING (arm that swelled after a wasp stung) and PERIPHERAL SWELLING (arm swelled all the way up to the elbow/it just kept swelling) outcome was unknown.            No concomitant medications were provided by the reporter.   Patient was stung in early June and late June. She did not have any other bad reactions after vaccination.
L shoulder swollen and painful. No SOB, dizziness. Some numbness in L anterior arm. Recommended NSAIDs, BENADRYL and if needed prednisone Erx done.
Pt developed slight dizziness/light-headedness after receiving vaccine dose. This resolved on its own in 5 minutes. Pt did not complain of any other adverse reactions.
Pt had whole body tremors, high fever, chills beginning that evening.  Had loss of mobility in left arm, swelling, pain, and rash.   Currently has somewhat reduced mobility in the arm, along with some swelling and the rash.
This spontaneous report as received from a pharmacy technician refers to a 16 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 23-APR-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1802USA001558.
PATIENT HAD PFIZER VACCINE ON  12/22/2020 and 1/21/21, AND TESTED POSITIVE TO COVID.
Lump under right armpit.  No pain. I had headache the following day but is resolved now. I was sleeping the whole day Sunday. I did not take any medication but kept myself hydrated. I noticed a swelling in my armpit Monday morning.
she has had all the vaccines and boosters and she still got the virus four times; she has had all the vaccines and boosters and she still got the virus four times; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 92-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) and as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "she has had all the vaccines and boosters and she still got the virus four times". The reporter stated that her mother is 92-year-old, and she has had all the vaccines and boosters and she still got the virus four times and got worse after she took another booster. [Note: unknown what vaccine(s) this person received].  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201332944 same patient, different vaccine number/event;
Patient states that last evening she noted a burning sensation around her mouth with associated swelling and rash around her mouth. She also noted shortly thereafter that she noted a rash on her upper extremity bilaterally. Reports associated pruritus. She denies any associated SOB, difficulty breathing, sensation of her throat closing in on her.
Information has been received from a pharmacist concerning a 66 year old female who on 04-MAR-2008 was vaccinated with zoster vaccine live (Oka/Merck) (lot # 658396/0967U). Concomitant therapy included BACTRIM and CIPRO. In March 2008, the patient had a urinary tract infection and was taking BACTRIM at the time of vaccination. The patient was switched to CIPRO for the UTI that does not seem to be responding to treatment. Medical attention was sought in the doctor's office. At the time of the report the patient had not recovered. There was no product quality complaint involved. Additional information has been requested.
Reactions; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Reactions) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Reactions). At the time of the report, ADVERSE REACTION (Reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Details regarding adverse event, concomitant medications and treatment medications were not provided.
Hot at the injection site; Hardness at the injection site; Swelling at the injection site; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot at the injection site), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot at the injection site), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). At the time of the report, VACCINATION SITE WARMTH (Hot at the injection site), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment medications was provided.   Reporter did not allow further contact
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.).    The Beyond use date (BUD) of the vaccine was reported as 21-May-2021. Patient received the vaccine at a Pharmacy.  No concomitant medication reported. No treatment medication reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up document received on 24-Jan-2023 with no new significant information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master case
Patient never received any COVID-19 vaccine prior to this dose (08/21/23). Patient was supposed to receive Moderna Bivalent Blue cap, but this writer gave patient Moderna Bivalent Dark Pink cap 6mo-5 yo vaccine. This writer had checked with patient's family, and patient's family stated patient was totally fine after receiving Moderna Bivalent Dark Pink cap 6mo-5yo and didn't experience any symptoms or adverse reaction.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 19-AUG-2015, the patient was vaccinated with an improperly stored dose of VAQTA (lot # L009445, exp. date: 01-JUN-2017) (strength, dose and route were not reported). There were no adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Patient reported blacking out, temporary vision/hearing loss, dizziness, and throat felt tight  Black out phase lasted roughly 5 minutes until patient showed improvement and progressively had no symptoms anymore after 30 minutes
The mother stated the child had a fever of 103 and went to the ER for treatment. The ER physician recommended Tylenol alternated with Motrin every 3 hours until fever decreases.
Within a couple minutes I began having tingling of my chin that worked up to my forehead. My throat felt like I had a lump in it. I felt off like I may pass out. My vision seemed a little blurry. This lasted about an hour. I felt itchy all over my body. This lasted for several hours.
D68.9 COAGULOPATHY, UNSPECIFIED TYPE 2/2/2022 ACUTE LOWER RESPIRATORY INFECTION J96.00 ACUTE RESPIRATORY FAILURE 6/8/2022 ACUTE LOWER RESPIRATORY INFECTION J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 6/8/2022 ACUTE LOWER RESPIRATORY INFECTION J96.20 ACUTE ON CHRONIC RESPIRATORY FAILURE 6/8/2022 ACUTE LOWER RESPIRATORY INFECTION
This spontaneous report was received from a registered nurse refers to a female patient of unknown age. The patient was vaccinated with a first and a second doses of GARDASIL, (doses, route and lot numbers not reported) on 2008. On 17-JUL-2012, the patient was in the nurse's office and received a third dose of doses of GARDASIL, (dose, route and lot numbers not reported). No adverse event reported. Additional information is not expected.